Phase II trial of navelbine and fluorouracil as second-line chemotherapy in metastatic breast carcinoma

被引：12
|
作者：
Froudarakis, ME [1 ]
Catimel, G [1 ]
Guastalla, JP [1 ]
Rebattu, P [1 ]
Clavel, M [1 ]
机构：
[1] Ctr Leon Berard, Dept Clin Pharmacol, F-69373 Lyon, France
来源：
ONCOLOGY | 1998年 / 55卷 / 01期
关键词：
D O I：
10.1159/000011840
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：87 / 88
页数：2
相关论文
共 50 条
  • [1] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Baur, Martina
    van Oosterom, Allan T.
    Dieras, Veronique
    Tubiana-Hulin, Michele
    Coombes, R. Charles
    Hatschek, Thomas
    Murawsky, Michael
    Klink-Alakl, May
    Hudec, Marcus
    Dittrich, Christian
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2008, 134 (02) : 125 - 135
  • [2] A phase II trial of docetaxel (Taxotere®) as second-line chemotherapy in patients with metastatic breast cancer
    Martina Baur
    Allan T. van Oosterom
    Véronique Diéras
    Michele Tubiana-Hulin
    R. Charles Coombes
    Thomas Hatschek
    Michael Murawsky
    May Klink-Alakl
    Marcus Hudec
    Christian Dittrich
    [J]. Journal of Cancer Research and Clinical Oncology, 2008, 134 : 125 - 135
  • [3] Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma
    Matthew D. Galsky
    Svetlana Mironov
    Alexia Iasonos
    Joseph Scattergood
    Mary G. Boyle
    Dean F. Bajorin
    [J]. Investigational New Drugs, 2007, 25 : 265 - 270
  • [4] Phase II trial of pemetrexed as second-line therapy in patients with metastatic urothelial carcinoma
    Galsky, Matthew D.
    Mironov, Svetlana
    Iasonos, Alexia
    Scattergood, Joseph
    Boyle, Mary G.
    Bajorin, Dean F.
    [J]. INVESTIGATIONAL NEW DRUGS, 2007, 25 (03) : 265 - 270
  • [5] Second-line chemotherapy of metastatic malignant melanoma with intravenous treosulfan:: a phase II multicentre trial
    Neuber, K
    Reinhold, U
    Deutschmann, A
    Pföhler, C
    Mohr, P
    Pichlmeier, U
    Baumgart, J
    Hauschild, A
    [J]. MELANOMA RESEARCH, 2003, 13 (01) : 81 - 85
  • [6] A Phase II Study of Weekly Docetaxel as Second-Line Chemotherapy in Patients With Metastatic Urothelial Carcinoma
    Kim, Young Saing
    Lee, Soon Il
    Park, Se Hoon
    Park, Silvia
    Hwang, In Gyu
    Lee, Sang-Cheol
    Sun, Jong-Mu
    Lee, Jeeyun
    Lim, Ho Yeong
    [J]. CLINICAL GENITOURINARY CANCER, 2016, 14 (01) : 76 - 81
  • [7] A phase II trial of temsirolimus in second-line metastatic urothelial cancer
    Gerullis, H.
    Eimer, C.
    Ecke, T. H.
    Georgas, E.
    Freitas, C.
    Kastenholz, S.
    Arndt, C.
    Heusch, C.
    Otto, T.
    [J]. MEDICAL ONCOLOGY, 2012, 29 (04) : 2870 - 2876
  • [8] A phase II trial of temsirolimus in second-line metastatic urothelial cancer
    H. Gerullis
    C. Eimer
    T. H. Ecke
    E. Georgas
    C. Freitas
    S. Kastenholz
    C. Arndt
    C. Heusch
    T. Otto
    [J]. Medical Oncology, 2012, 29 : 2870 - 2876
  • [9] Phase II trial of pyrazoloacridine as second-line therapy for patients with unresectable or metastatic transitional cell carcinoma
    Dodd, PM
    McCaffrey, JA
    Mazumdar, M
    Icasiano, E
    Higgins, G
    Herr, H
    Bajorin, DF
    [J]. INVESTIGATIONAL NEW DRUGS, 2000, 18 (03) : 247 - 251
  • [10] Phase II Trial of Pyrazoloacridine as Second-Line Therapy for Patients with Unresectable or Metastatic Transitional Cell Carcinoma
    Paul M. Dodd
    John A. McCaffrey
    Madhu Mazumdar
    Evelyn Icasiano
    Geralyn Higgins
    Harry Herr
    Dean F. Bajorin
    [J]. Investigational New Drugs, 2000, 18 : 247 - 251
12345